Somewhat Favorable Press Coverage Somewhat Unlikely to Impact National Health Investors (NHI) Stock Price
News coverage about National Health Investors (NYSE:NHI) has been trending somewhat positive this week, according to Accern Sentiment. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. National Health Investors earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned media headlines about the real estate investment trust an impact score of 45.4086216551264 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the media headlines that may have effected Accern Sentiment’s rankings:
- National Health Investors, Inc. : NHI-US: Dividend Analysis : September 29th, 2017 (record date) : By the numbers : October 13, 2017 (finance.yahoo.com)
- SunTrust Banks Weighs in on National Health Investors, Inc.’s Q3 2017 Earnings (NHI) (americanbankingnews.com)
- Head-To-Head Contrast: National Health Investors (NHI) and Its Competitors (americanbankingnews.com)
- Comparing National Health Investors (NHI) and Community Healthcare Trust (CHCT) (americanbankingnews.com)
- National Health Investors (NHI) vs. The Competition Financial Survey (americanbankingnews.com)
Shares of National Health Investors (NYSE:NHI) opened at 77.49 on Monday. The stock has a 50 day moving average price of $78.75 and a 200 day moving average price of $76.90. National Health Investors has a one year low of $66.31 and a one year high of $81.21. The company has a market capitalization of $3.18 billion, a PE ratio of 19.90 and a beta of 0.56.
National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). The company had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.22 earnings per share. On average, equities research analysts predict that National Health Investors will post $3.86 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Investors of record on Friday, September 29th will be paid a $0.95 dividend. This represents a $3.80 dividend on an annualized basis and a yield of 4.90%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio is presently 97.69%.
NHI has been the topic of a number of recent analyst reports. Stifel Nicolaus raised their price target on National Health Investors from $80.00 to $82.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Mizuho reissued a “neutral” rating on shares of National Health Investors in a report on Wednesday, June 28th. BidaskClub raised National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, June 29th. Finally, Zacks Investment Research cut National Health Investors from a “buy” rating to a “sell” rating in a report on Tuesday, July 18th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company. National Health Investors currently has an average rating of “Hold” and a consensus price target of $80.17.
TRADEMARK VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/16/somewhat-favorable-press-coverage-somewhat-unlikely-to-impact-national-health-investors-nhi-stock-price.html.
In other National Health Investors news, insider Kevin Carlton Pascoe sold 2,000 shares of the stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $79.80, for a total value of $159,600.00. Following the completion of the sale, the insider now owns 21,228 shares in the company, valued at approximately $1,693,994.40. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 5.19% of the stock is currently owned by corporate insiders.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.